Novocure Net Income Applicable To Common Shares from 2010 to 2026
| NVCR Stock | USD 13.02 0.62 4.55% |
Net Loss | First Reported 2013-12-31 | Previous Quarter -57.4 M | Current Value -49.5 M | Quarterly Volatility 37.2 M |
Check Novocure financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novocure's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.2 M, Interest Expense of 9.2 M or Selling General Administrative of 229.2 M, as well as many indicators such as Price To Sales Ratio of 5.8, Dividend Yield of 0.0 or PTB Ratio of 13.13. Novocure financial statements analysis is a perfect complement when working with Novocure Valuation or Volatility modules.
Novocure | Net Income Applicable To Common Shares | Build AI portfolio with Novocure Stock |
Latest Novocure's Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of Novocure over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Novocure's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Novocure's overall financial position and show how it may be relating to other accounts over time.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
Net Income Applicable To Common Shares |
| Timeline |
Novocure Net Income Applicable To Common Shares Regression Statistics
| Arithmetic Mean | (76,490,171) | |
| Geometric Mean | 67,681,912 | |
| Coefficient Of Variation | (48.49) | |
| Mean Deviation | 24,877,277 | |
| Median | (77,370,000) | |
| Standard Deviation | 37,091,491 | |
| Sample Variance | 1375.8T | |
| Range | 151.7M | |
| R-Value | (0.06) | |
| Mean Square Error | 1462.5T | |
| R-Squared | 0 | |
| Significance | 0.82 | |
| Slope | (428,949) | |
| Total Sum of Squares | 22012.5T |
Novocure Net Income Applicable To Common Shares History
About Novocure Financial Statements
Novocure shareholders use historical fundamental indicators, such as Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Although Novocure investors may analyze each financial statement separately, they are all interrelated. The changes in Novocure's assets and liabilities, for example, are also reflected in the revenues and expenses on on Novocure's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Loss | -106.4 M | -111.7 M |
Pair Trading with Novocure
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Novocure position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novocure will appreciate offsetting losses from the drop in the long position's value.Moving against Novocure Stock
| 0.58 | 688656 | HOB Biotech Group | PairCorr |
| 0.4 | SPEC | Inspecs Group plc | PairCorr |
| 0.4 | EW | Edwards Lifesciences Corp | PairCorr |
The ability to find closely correlated positions to Novocure could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Novocure when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Novocure - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Novocure to buy it.
The correlation of Novocure is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Novocure moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Novocure moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Novocure can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Novocure Stock Analysis
When running Novocure's price analysis, check to measure Novocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novocure is operating at the current time. Most of Novocure's value examination focuses on studying past and present price action to predict the probability of Novocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novocure's price. Additionally, you may evaluate how the addition of Novocure to your portfolios can decrease your overall portfolio volatility.